177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Stephen Graves, Ph.D., DABR
University of Iowa
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Holden Comprehensive Cancer Center at the University of Iowa
Iowa City, Iowa, United States
David Bushnell, MDJanet Pollard, MDKristin Plichta, MD, PhDMichael Graham, MD, PhDParren McNeely, MDStephen Graves, PhDYusuf Menda, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 May 2024
- Primary completion
- 31 Dec 2029
- Completion
- 31 Dec 2029
- Last update posted
- 22 Jul 2025
- Registered enrollment
- 120
- Registry id
- NCT06395402
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.